Epigral Ltd. (EPIGRAL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has a cash flow conversion efficiency ratio of 0.127x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.67 Billion ≈ $28.91 Million USD) by net assets (Rs21.01 Billion ≈ $227.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EPIGRAL company net worth for the company's overall valuation and market capitalisation.
Epigral Ltd. - Cash Flow Conversion Efficiency Trend (2015–2026)
This chart illustrates how Epigral Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Epigral Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Epigral Ltd. ranked by their cash flow conversion efficiency. Explore Epigral Ltd. (EPIGRAL) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Veradigm Inc.
NASDAQ:MDRX
|
0.024x |
|
Anhui Xinli Finance Co Ltd
SHG:600318
|
0.060x |
|
GS P&L CO LTD
KO:499790
|
0.028x |
|
Zhenhai PetroChem Engineering
SHG:603637
|
0.031x |
|
Velesto Energy Bhd
KLSE:5243
|
0.016x |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
0.056x |
|
Invesco Quality Municipal Income Closed Fund
NYSE:IQI
|
0.018x |
|
Anglo American PLC
LSE:AAL
|
0.115x |
Annual Cash Flow Conversion Efficiency for Epigral Ltd. (2015–2026)
The table below shows the annual cash flow conversion efficiency of Epigral Ltd. from 2015 to 2026. View EPIGRAL live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs22.21 Billion ≈ $240.24 Million |
Rs3.88 Billion ≈ $41.92 Million |
0.174x | -24.57% |
| 2025-03-31 | Rs19.05 Billion ≈ $205.97 Million |
Rs4.41 Billion ≈ $47.64 Million |
0.231x | -27.04% |
| 2024-03-31 | Rs12.54 Billion ≈ $135.63 Million |
Rs3.98 Billion ≈ $43.00 Million |
0.317x | -45.86% |
| 2023-03-31 | Rs10.69 Billion ≈ $115.62 Million |
Rs6.26 Billion ≈ $67.72 Million |
0.586x | +49.81% |
| 2022-03-31 | Rs7.26 Billion ≈ $78.51 Million |
Rs2.84 Billion ≈ $30.69 Million |
0.391x | +16.69% |
| 2021-03-31 | Rs6.84 Billion ≈ $73.99 Million |
Rs2.29 Billion ≈ $24.79 Million |
0.335x | +18.71% |
| 2020-03-31 | Rs5.83 Billion ≈ $63.10 Million |
Rs1.65 Billion ≈ $17.81 Million |
0.282x | -46.78% |
| 2019-03-31 | Rs4.93 Billion ≈ $53.29 Million |
Rs2.61 Billion ≈ $28.26 Million |
0.530x | +22.00% |
| 2018-03-31 | Rs5.17 Billion ≈ $55.95 Million |
Rs2.25 Billion ≈ $24.32 Million |
0.435x | +13.58% |
| 2017-03-31 | Rs3.62 Billion ≈ $39.12 Million |
Rs1.38 Billion ≈ $14.97 Million |
0.383x | -8.46% |
| 2016-03-31 | Rs2.95 Billion ≈ $31.92 Million |
Rs1.23 Billion ≈ $13.35 Million |
0.418x | -17.91% |
| 2015-03-31 | Rs2.20 Billion ≈ $23.82 Million |
Rs1.12 Billion ≈ $12.13 Million |
0.509x | -- |
About Epigral Ltd.
Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power pl… Read more